GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (XSWX:BION) » Definitions » Total Noninterest Expense

BB Biotech AG (XSWX:BION) Total Noninterest Expense : CHF20.23 Mil (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is BB Biotech AG Total Noninterest Expense?

BB Biotech AG's Total Noninterest Expense for the three months ended in Dec. 2023 was CHF2.02 Mil. BB Biotech AG's Total Noninterest Expense for the trailing twelve months (TTM) ended in Dec. 2023 was CHF20.23 Mil.


BB Biotech AG Total Noninterest Expense Historical Data

The historical data trend for BB Biotech AG's Total Noninterest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Total Noninterest Expense Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Noninterest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.74 7.98 8.52 6.52 6.96

BB Biotech AG Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Noninterest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.56 1.75 8.79 7.67 2.02

BB Biotech AG Total Noninterest Expense Calculation

Total Noninterest Expense is any expenses incurred that not related to interest. It includes:
Selling, General, & Admin. Expense
Occupancy
Equipment
Professional fees
Amortization of intangibles
Any other special income/charges (too numerous to list)
Some banks can do choose to report each of these items separately. Yet, there are a variety of noninterest expense which are simply too numerous to list.

Total Noninterest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF20.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BB Biotech AG Total Noninterest Expense Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Total Noninterest Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (XSWX:BION) Business Description

Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.
Executives
Prof. Dr. Mads Krogsgaard Thomsen Supervisory Board

BB Biotech AG (XSWX:BION) Headlines

No Headlines